Page last updated: 2024-10-28

hypericin and Esophageal Neoplasms

hypericin has been researched along with Esophageal Neoplasms in 1 studies

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research Excerpts

ExcerptRelevanceReference
"Hypericin is a very promising new photosensitizer for innovative photodynamic therapy of esophageal cancer."1.32Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. ( Höpfner, M; Kashtan, H; Lenz, M; Maaser, K; Riecken, EO; Scherübl, H; Sutter, AP; Theiss, A; von Lampe, B; Zeitz, M, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Höpfner, M1
Maaser, K1
Theiss, A1
Lenz, M1
Sutter, AP1
Kashtan, H1
von Lampe, B1
Riecken, EO1
Zeitz, M1
Scherübl, H1

Other Studies

1 other study available for hypericin and Esophageal Neoplasms

ArticleYear
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
    International journal of colorectal disease, 2003, Volume: 18, Issue:3

    Topics: Adenocarcinoma; Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Carcinoma, Squam

2003